The Anti-SSA/Ro antibody test detects autoantibodies against the SSA (Ro) protein, which plays a role in RNA processing. It is commonly used to diagnose Sjogren’s syndrome, systemic lupus erythematosus (SLE), and neonatal lupus.
✅ Diagnose Sjogren’s syndrome (primary or secondary)
✅ Support the diagnosis of systemic lupus erythematosus (SLE)
✅ Evaluate autoimmune-related dry eyes, dry mouth, or systemic symptoms
✅ Assess pregnancy risk for neonatal lupus & congenital heart block
| Result | Interpretation |
|---|---|
| Negative | No detectable Anti-SSA/Ro antibodies (does not rule out autoimmune disease) |
| Low Positive | Possible early or mild autoimmune activity, clinical correlation needed |
| High Positive | Strongly associated with Sjogren’s syndrome, SLE, or neonatal lupus |
🔹 Anti-SSA/Ro antibodies are found in:
75-90% of Sjogren’s syndrome cases (often with Anti-SSB/La).
30-50% of SLE cases, especially ANA-negative lupus.
Neonatal lupus & congenital heart block (CHB) when found in pregnant women.
Primary Sjogren’s Syndrome → High Anti-SSA/Ro is a key diagnostic marker.
Secondary Sjogren’s Syndrome → Often present alongside rheumatoid arthritis (RA) or lupus (SLE).
Lupus (SLE) → Anti-SSA/Ro is linked to photosensitivity, rashes, and ANA-negative lupus.
Neonatal Lupus & Congenital Heart Block (CHB) → Pregnant women with Anti-SSA/Ro have an increased risk of fetal heart block (5-10% chance).
✔ Anti-SSB/La Antibodies → Also common in Sjogren’s and SLE.
✔ ANA (Antinuclear Antibody Test) → Usually positive in autoimmune diseases.
✔ Rheumatoid Factor (RF) → Positive in secondary Sjogren’s syndrome (RA-associated).
✔ Schirmer’s Test & Salivary Gland Biopsy → Confirms Sjogren’s syndrome.
✔ Complement Levels (C3, C4) → Can be low in active lupus.
✔ Fetal Echocardiogram (if pregnant with positive SSA/Ro) → Monitors congenital heart block risk.
🔹 Evaluate symptoms (dry eyes, dry mouth, fatigue, joint pain, photosensitivity).
🔹 Consider ophthalmology & dental evaluation for Sjogren’s complications.
🔹 Regular monitoring with a rheumatologist for SLE or Sjogren’s progression.
🔹 Pregnancy monitoring (if applicable) with fetal echocardiograms at 16-26 weeks to check for CHB.